ODAK - News

ODAK exhibit at EuCornea 2017

The ODAK consortium, represented by Ceratium Ltd and SIFI SpA attended EuCornea 2017 in Lisbon, Portugal. Opthalmologists from around the globe were enlisted to participate in a AK awareness/prevalence survey. Click here to take the survey

Stand rh aa2

ODAK Phase 3 clinical trial opens for recruitment

The ODAK project announces the start of the Phase 3 clinical study with the opening of the first of six trial sites across Europe. Moorfields Eye Hospital in London (UK) opened for recruitment on 8th August 2017. To read the full press release CLICK HERE.

ODAK PHASE III trial approved by MHRA

The ODAK project has received approval from the regulatory authority in the UK for the Phase III clinical trial. 

ODAK Phase 3 clinical trial Investigator meeting held in London

The ODAK project held the Phase 3 clinical trial Investigator meeting at Moorfields Eye Hospital in London on 17th and 18th March 2017. Investigators from trial sites in Poland, Italy and the UK, met with the ODAK project team and undertook trial preparation.

 2017 03 18 11.12.402017 03 18 13.10.12

ODAK presents at IRDiRC conference

Dr Ritchie Head presented the latest project results at the 3rd IRDiRC conference, held in Paris on February 8-9 2017.